This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Achalasia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Achalasia is an oesophageal smooth muscle motility disorder:

  • failure of relaxation at the lower oesophageal sphincter
  • progressive dilatation, tortuosity, incoordination of peristalsis and hypertrophy of the oesophagus
  • functional obstruction at the lower end of the oesophagus.

Achalasia may occur at any age but particularly in the second to fifth decade of life with peak incidence between ages 30 to 60 years. Males and females are affected equally (1,2).

Annual incidence is about 1 per 100,000 and prevalence of 10 per 100,000 (1).

Chronic opioid use (COU)

  • study evidence revealed that chronic opioid use (COU) was associated with an increased frequency of oesophageal dysmotility disorders (ODD) e.g type III achalasia (pooled OR 4.15, 95% CI 2.15-8.03, p<0.0001) but not type I or II achalasia (3)
    • study authors stated that COU should be considered as a risk factor when diagnosing ODD

References:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.